Official Patient Advocacy Organisations to the ExTINGUISH Trial
A summary of this report with MedWorm recommendations of related news links and other reading to help further your research.
N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors important for synaptic plasticity, memory, and neuropsychiatric health. NMDAR hypofunction contributes to multiple disorders, including anti-NMDAR encephalitis (NMDARE), an autoimmune disease of the central nervous system associated with GluN1 antibody-mediated NMDAR internalization. Here we characterize the functional/pharmacological consequences of exposure to cerebrospinal fluid (CSF) from female human NMDARE patients on NMDAR function, and we characterize the effects of intervention with recently described positive allosteric modulators (PAMs) of NMDARs. Incubation (48 h) of rat hippocampal neurons of both sexes in confirmed NMDARE patient CSF, but not control CSF, attenuated NMDA-induced current. Residual NMDAR function was characterized by lack of change in channel open probability, indiscriminate loss of synaptic and extrasynaptic NMDARs, and indiscriminate loss of GluN2B-containing and GluN2B-lacking NMDARs. NMDARs tagged with N-terminal pHluorin fluorescence demonstrated loss of surface receptors. Thus, function of residual NMDARs following CSF exposure was indistinguishable from baseline, and deficits appear wholly accounted for by receptor loss. Co-application of CSF and PAMs of NMDARs (SGE-301 or SGE-550, oxysterol-mimetic) for 24 h restored NMDAR function following 24 h incubation in patient CSF. Curiously, restoration of NMDAR function was observed despite wash-out of PAMs prior to electrophysiological recordings. Subsequent experiments suggested that residual allosteric potentiation of NMDAR function explained the persistent rescue. Further studies of the pathogenesis of NMDARE and intervention with PAMs may inform new treatments for NMDARE and other disorders associated with NMDAR hypofunction.
Significance statement: Anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) is increasingly recognized as an important cause of sudden-onset psychosis and other neuropsychiatric symptoms. Current treatment leaves unmet medical need. Here we demonstrate cellular evidence that newly identified positive allosteric modulators of NMDAR function may be a viable therapeutic strategy.
In the surgical case of a mature cystic teratoma of the ovary that arose in a 16‐year‐old girl, a large amount of well‐differentiated and highly organized cerebellar tissue was found. Three layers o
Many cases of encephalitis are caused by an autoimmune disorder which may or may not be triggered by an infection. Here is a shor
The journal focuses on neuroimmunology and neuroinflammation, and the coverage extends to other basic and clinical studies related to neuroscience including molecular biology, psychology, pathology, physiology, endocrinology, pharmacology, oncology, etc.
It was a cold March day as I walked to work from my Hell’s Kitchen studio. The weather was clear, people were out in their coats and scarves
Anti–NMDA receptor (anti-NMDAR) encephalitis was first described in 20071 and is now recognized as one of the most common forms of encephalitis.2 Anti-NMDAR encephalitis is considered a multistage disease, characterized by nonspecific prodromal flu-like symptoms, followed by acute onset of psychiatric manifestations such as psychosis, delusions, hallucinations, anxiety, insomnia, repetitive behaviors, echolalia, and mutism. Patients at this stage generally present to either neurology or psychiatry services. This phase is usually followed by a change in level of alertness with periods of extreme agitation and catatonia along with the appearance of the classic orofacial and lingual dyskinesias or other movement disorders and pronounced autonomic instability. The combination of autonomic storms and coma often leads to a prolonged intensive care unit (ICU) admission. Patients—children in particular—can also develop focal or generalized seizures. Anti-NMDAR encephalitis can be associated with a tumor, especially ovarian teratomas in female patients older than 12 years. Brain MRI is normal in up to 67% of patients, whereas EEG is abnormal in 90% of patients.3 EEG findings are nonspecific and can include slowing, disorganization of the background, and electrographic seizures. The diagnosis is confirmed by the presence of NMDAR antibodies in the CSF.
Anti-N-Methyl-d-aspartate-receptor (NMDAR) encephalitis is the most frequent autoimmuneencephalitis in pediatric age. This retrospective observational study was aimed atdescribing the clinical characteristics of the disease in a cohort of children andteenagers. Eighteen patients (10 females and 8 males), with a median age of 12.4 yearsat symptom onset were enrolled. The clinical presentation of the disease was markedby neurological manifestations in 13 patients and by severe psychiatric and behavioralsymptoms in 5.
Curr Med Chem. 2018 Feb 21. doi: 10.2174/0929867325666180221142623. [Epub ahead of print]
Research Article You have free access to this content Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis Divyanshu Dubey MD1, Sean J. Pittock MD1,2, Cecilia R. Kelly MD1, Andrew McKeon MD1,2, Alfonso Sebastian Lopez-Chiriboga MD1, Vanda A.